Cirrhosis News and Research

Latest Cirrhosis News and Research

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Biochemist Jon Jacobs has analyzed the blood of patients with diseases and conditions such as Ebola, cancer, tuberculosis, hepatitis, diabetes, Lyme disease, brain injury and influenza.

9 Feb 2023

Exercise can be used as a treatment for nonalcoholic fatty liver disease

The 150 minutes of moderate to intense aerobic activity per week that is recommended by the U.S. Department of Health and Human Services can significantly reduce liver fat, according to new research by Penn State College of Medicine researchers.

9 Feb 2023

Exercise can lead to meaningful reductions in liver fat for patients with NAFLD, research confirms

Penn State College of Medicine researchers confirmed exercise can lead to meaningful reductions in liver fat for patients with nonalcoholic fatty liver disease.

8 Feb 2023

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the publication of a peer-reviewed study in the Journal of Clinical and Translational Hepatology, “Breath Biopsy to identify exhaled volatile organic compounds as biomarkers for liver cirrhosis detection”.

From Owlstone Medical Ltd 7 Feb 2023

New recommendations for optimization, validation of the quantitative measurement of HBV cccDNA

Approximately 300 million people worldwide are chronically infected with the hepatitis B virus (HBV) and at high risk of developing liver cirrhosis or hepatocellular carcinoma.

6 Feb 2023

Gut hormone receptor polyagonists show promise for obesity and diabetes

A new paper in the Journal of Clinical Investigation describes drugs that could help lose weight and manage type 2 diabetes mellitus (T2DM).

6 Feb 2023

Liver cancer treatment can place significant financial burden on patients, analysis shows

Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.

30 Jan 2023

Researchers uncover new mechanism that plays key role in the progression of alcohol-related liver disease

Alcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of the factors contributing to disease development, liver transplantation is still the only available cure.

24 Jan 2023

Eating fast food associated with nonalcoholic fatty liver disease

The new year has begun, and with it, resolutions for change. A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology gives people extra motivation to reduce fast-food consumption.

10 Jan 2023

Hair follicle transplants can rejuvenate scars, study finds

In a new study involving three volunteers, skin scars began to behave more like uninjured skin after they were treated with hair follicle transplants.

6 Jan 2023

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Many public health warnings have been issued against alcohol consumption, even in small quantities, though the evidence for such strict limits is controversial. The current study, published in the MDPI journal Nutrients, is a narrative review focused on clearing up some of the confusion associated with alcoholic drinks.

4 Jan 2023

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Using the latest technologies - including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells - researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD).

4 Jan 2023

The metabolic links between diet-induced changes in the gut and NASH

Scientists reviewed the metabolic association between diet-induced alterations in the gut and NASH

4 Jan 2023

Discovery could pave the way for developing therapies to treat nonalcoholic steatohepatitis

UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.

27 Dec 2022

Brief roundup of research done by experts at UCLA Health

Below is a brief roundup of news and story ideas from the experts at UCLA Health.

21 Dec 2022

Study examines the association of dementia diagnosis with risk of COVID-19 mortality

Since December 2019, more than 60 million people have been diagnosed with coronavirus disease 2019 (COVID-19) worldwide, while approximately six million individuals have died as a result of the disease.

20 Dec 2022

Individuals with alcohol use disorder less likely to receive treatment for hepatitis C, study shows

A new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines recommending antiviral treatment regardless of alcohol use.

14 Dec 2022

Scientists provide evidence of the positive effects of alcohol abstinence in advanced liver cirrhosis

Complete abstinence from alcohol is considered a cornerstone in the treatment of patients with alcohol-related liver disease. It has not yet been sufficiently researched whether this measure can still improve the prognosis even in the case of advanced liver cirrhosis.

14 Dec 2022

Alcohol's toll on health, safety and economy in Massachusetts is very concerning

Alcohol's health, safety and economic toll on the Bay State residents far outstrips revenues from state alcohol taxes, according to a new report from Boston University School of Public Health (BUSPH).

13 Dec 2022

Hepatitis B virus haplotype number is a predictive marker of functional cure during antiviral therapies

Patients with a lower hepatitis B virus haplotype number are more likely to achieve a functional cure with chronic hepatitis B treatment.

4 Dec 2022

Cirrhosis News and Research

Latest Cirrhosis News and Research

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Exercise can be used as a treatment for nonalcoholic fatty liver disease

Exercise can lead to meaningful reductions in liver fat for patients with NAFLD, research confirms

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

New recommendations for optimization, validation of the quantitative measurement of HBV cccDNA

Gut hormone receptor polyagonists show promise for obesity and diabetes

Liver cancer treatment can place significant financial burden on patients, analysis shows

Researchers uncover new mechanism that plays key role in the progression of alcohol-related liver disease

Eating fast food associated with nonalcoholic fatty liver disease

Hair follicle transplants can rejuvenate scars, study finds

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

The metabolic links between diet-induced changes in the gut and NASH

Discovery could pave the way for developing therapies to treat nonalcoholic steatohepatitis

Brief roundup of research done by experts at UCLA Health

Study examines the association of dementia diagnosis with risk of COVID-19 mortality

Individuals with alcohol use disorder less likely to receive treatment for hepatitis C, study shows

Scientists provide evidence of the positive effects of alcohol abstinence in advanced liver cirrhosis

Alcohol's toll on health, safety and economy in Massachusetts is very concerning

Hepatitis B virus haplotype number is a predictive marker of functional cure during antiviral therapies

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Cirrhosis News and Research

Latest Cirrhosis News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in